Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
11 Patents
#13 in Union City, CA
#6,548 in California
#27,563 in US
#51,873 in the World
Bexel Pharmaceuticals, Inc.
Forward Citations = 37
21 inventors:
Union City, CA, United States of America
Bexel Pharmaceuticals, Inc.
Calculating rank
% Expired Patents = 90.9
CIPO Patents = 1
EPO Patents = 2
Forward Citations = 37
Loading Chart...
Loading Chart...
21 inventors (with patents filed for the assignee):
Debendranath Dey (8 out of 19 patents)
Shiv Kumar Agarwal (8 out of 9 patents)
Bishwajit Nag (7 out of 42 patents)
4. Partha Neogi (6 out of 16 patents)
5. Abhijeet Nag (5 out of 5 patents)
6. Ravikumar Tadiparthi (4 out of 23 patents)
7. Pawan Aggarwal (4 out of 5 patents)
8. Savithiri Shivakumar (4 out of 4 patents)
9. Surendra Kumar Pandey (3 out of 3 patents)
10. Abjiheet Nag (2 out of 2 patents)
11. Birendra Kumar Bhattacharya (1 out of 1 patent)
12. Vinod Kumar Singh (1 out of 1 patent)
13. Surendradoss Jayakumar (1 out of 1 patent)
14. Sangamesh Badiger (1 out of 1 patent)
15. Gajendra Singh (1 out of 1 patent)
11 patents:
Company Overview
Bexel Pharmaceuticals, Inc. is a biopharmaceutical company based in Union City, California, specializing in the development and manufacturing of innovative drug products. The organization focuses on enhancing therapeutic options across various medical fields, leveraging advanced research in pharmaceutical formulations and delivery systems. With a commitment to quality and efficacy, Bexel aims to address unmet medical needs and improve patient outcomes through its diverse portfolio of pharmaceutical solutions.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bexel Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/bexel-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]